These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30906989)

  • 1. Relationship between psoriasis and non-alcoholic fatty liver disease - Updated systematic review and adjusted meta-analysis.
    Phan K; Onggo J; Charlton O; Smith SD
    Australas J Dermatol; 2019 Nov; 60(4):e352-e355. PubMed ID: 30906989
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between Non-Alcoholic Fatty Liver Disease and Psoriasis: A Novel Hepato-Dermal Axis?
    Mantovani A; Gisondi P; Lonardo A; Targher G
    Int J Mol Sci; 2016 Feb; 17(2):217. PubMed ID: 26861300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease fibrosis score in patients with psoriasis.
    Gisondi P; Barba E; Girolomoni G
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):282-7. PubMed ID: 26537011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Prevalence of Advanced Liver Fibrosis in Patients with Psoriasis: A Cross-sectional Analysis from the Rotterdam Study.
    van der Voort EA; Koehler EM; Nijsten T; Stricker BH; Hofman A; Janssen HL; Schouten JN; Wakkee M
    Acta Derm Venereol; 2016 Feb; 96(2):213-7. PubMed ID: 26062958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.
    Candia R; Ruiz A; Torres-Robles R; Chávez-Tapia N; Méndez-Sánchez N; Arrese M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):656-62. PubMed ID: 25418531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality.
    Athyros VG; Doumas M
    Curr Vasc Pharmacol; 2018; 16(3):206-208. PubMed ID: 29598814
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis and Nonalcoholic Fatty Liver Disease.
    Carrascosa JM; Bonanad C; Dauden E; Botella R; Olveira-Martín A;
    Actas Dermosifiliogr; 2017; 108(6):506-514. PubMed ID: 28318525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis and non-alcoholic fatty liver disease.
    Schön MP
    J Dtsch Dermatol Ges; 2021 Apr; 19(4):503-504. PubMed ID: 33861024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
    van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
    J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic.
    Roberts KK; Cochet AE; Lamb PB; Brown PJ; Battafarano DF; Brunt EM; Harrison SA
    Aliment Pharmacol Ther; 2015 Feb; 41(3):293-300. PubMed ID: 25521607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Psoriasis With Comorbidity Development in Children With Psoriasis.
    Tollefson MM; Van Houten HK; Asante D; Yao X; Maradit Kremers H
    JAMA Dermatol; 2018 Mar; 154(3):286-292. PubMed ID: 29322175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to Approach a Patient With Nonalcoholic Fatty Liver Disease.
    Tilg H
    Gastroenterology; 2017 Aug; 153(2):345-349. PubMed ID: 28647352
    [No Abstract]   [Full Text] [Related]  

  • 14. Commonalities and Distinctions Between Alcoholic and Nonalcoholic Fatty Liver Disease.
    Sanyal AJ; Mathurin P; Nagy LA
    Gastroenterology; 2016 Jun; 150(8):1695-7. PubMed ID: 27155520
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Call to screen for NAFLD and NASH in psoriasis.
    Verna EC; Loomba R
    Aliment Pharmacol Ther; 2015 Mar; 41(5):492-3. PubMed ID: 25631653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Liver diseases. Non-alcoholic fatty liver disease].
    Bernal Reyes R
    Rev Gastroenterol Mex; 2010 Aug; 75 Suppl 1():181-3. PubMed ID: 20959244
    [No Abstract]   [Full Text] [Related]  

  • 17. [[113th Scientific Meeting of the Japanese Society of Internal Medicine: Educational Lecture: Diagnosis and Management of Non-alcoholic Fatty Liver Diseases and Non-alcoholic Steatohepatitis: Current Concepts].
    Hashimoto E
    Nihon Naika Gakkai Zasshi; 2016 Sep; 105(9):1753-60. PubMed ID: 30169948
    [No Abstract]   [Full Text] [Related]  

  • 18. The Prevalence of Nonalcoholic Fatty Liver Disease and Related Metabolic Comorbidities Was Associated with Age at Onset of Moderate to Severe Plaque Psoriasis: A Cross-Sectional Study.
    Xu X; Su L; Gao Y; Ding Y
    PLoS One; 2017; 12(1):e0169952. PubMed ID: 28099469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease: a new epidemic in children.
    Ciocca M; Ramonet M; Álvarez F
    Arch Argent Pediatr; 2016 Dec; 114(6):563-569. PubMed ID: 27869416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.
    Chalasani N; Younossi Z; Lavine JE; Charlton M; Cusi K; Rinella M; Harrison SA; Brunt EM; Sanyal AJ
    Hepatology; 2018 Jan; 67(1):328-357. PubMed ID: 28714183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.